Spots Global Cancer Trial Database for ≥2nd line treatment
Every month we try and update this database with for ≥2nd line treatment cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Phase 2 Safety and Efficacy Evaluation of AL8326 in ≥2nd Line SCLC | NCT05363280 | Small Cell Lung... | AL8326 low dose... AL8326 middle d... AL8326 high dos... | 18 Years - | Advenchen Laboratories, LLC |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
